<?xml version="1.0" encoding="UTF-8"?>
<p id="para0008">The potential hazards posed by each DMT differ and, rather than imposing a blanket rule, decisions regarding treatment should be individualised (See 
 <xref rid="tbl0001" ref-type="table">Table 1</xref> ) and discussed with patients. For some patients having their MS treated and controlled may be more important than the potential danger of being exposed to and acquiring a more severe COVID-19 infection. 
 <xref rid="tbl0001" ref-type="table">Table 1</xref> is our attempt to define the risks associated with the different classes of DMTs in the event of a patient acquiring a COVID-19 infection.
</p>
